¼³ÆÄ»ì¶óÁø(Sulfasalazine) ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Sulfasalazine Market, By Product Type, By Application, By End User, By Geography
»óǰÄÚµå : 1741363
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,269,000
Unprintable PDF & Excel (Single User License)
US $ 7,000 £Ü 9,753,000
PDF & Excel (Multi User License - Up to 7 Users)
US $ 10,000 £Ü 13,933,000
PDF & Excel (Corporate User License)


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼³ÆÄ»ì¶óÁø ½ÃÀåÀº 2025³â 22¾ï 4,000¸¸ ´Þ·¯, 2032³â¿¡´Â 33¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº 5.7%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

ºÐ¼® ¹üÀ§ ºÐ¼® »ó¼¼
±âÁØ ¿¬µµ 2024³â ½ÃÀå ±Ô¸ð(2025³â) 22¾ï 4,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ CAGR(2025-2032³â) 5.70% ¿¹Ãø ±Ý¾×(2032³â) 33¾ï ´Þ·¯

¼³ÆÄ»ì¶óÁøÀº ·ù¸¶Æ¼½º °üÀý¿°, ±Ë¾ç¼º ´ëÀå¿°, Å©·Ðº´°ú °°Àº ¿°Áõ¼º Àå ÁúȯÀÇ Ä¡·á¿¡ ÁÖ·Î »ç¿ëµÇ´Â Áúº´ º¯Çü Ç×·ù¸¶Æ¼½ºÁ¦(DMARD)·Î ºÐ·ùµÇ´Â ¾à¹°ÀÔ´Ï´Ù. ÀÌ ¾àÀº ¼³ÆÄÇǸ®µò°ú 5-¾Æ¹Ì³ë»ì¸®½Ç»ê(5-ASA)ÀÇ µ¶Æ¯ÇÑ Á¶ÇÕÀ¸·Î ¾Ë·ÁÁ® ÀÖÀ¸¸ç, µÑ ´Ù Ä¡·á È¿°ú¿¡ ±â¿©ÇÏ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù. ·ù¸¶Æ¼½º °üÀý¿°¿¡¼­ ¼³ÆÄ»ì¶óÁøÀº ¸é¿ª°è ¹ÝÀÀÀ» ¾ïÁ¦ÇÏ°í ¿°ÁõÀ» ¿ÏÈ­ÇÏ¸ç °üÀýÀÇ ÅëÁõ°ú ºÎÁ¾À» ¿ÏÈ­ÇÕ´Ï´Ù. ÀÌ ¸¸¼º ÀÚ°¡¸é¿ªÁúȯÀÇ Áõ»ó°ú ÁøÇàÀ» °ü¸®Çϱâ À§ÇÑ Á¾ÇÕÀûÀÎ Ä¡·á °èȹÀÇ ÀÏȯÀ¸·Î ó¹æµÇ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ¿°Áõ¼º Àå ÁúȯÀº ¼ÒÈ­°üÀÇ ¸¸¼º ¿°Áõ°ú °ü·ÃÀÌ ÀÖÀ¸¸ç, ¼³ÆÄ»ì¶óÁøÀÇ Ç׿°Áõ ÀÛ¿ëÀº ±Ë¾ç¼º ´ëÀå¿°°ú Å©·Ðº´°ú °ü·ÃµÈ Áõ»óÀ» Ä¡·áÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¼³ÆÄ»ì¶óÁøÀÇ 5-ASA ¼ººÐÀº ¼ÒÈ­°ü ³» Ç׿°Áõ ÀÛ¿ë¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù. ¼³ÆÄ»ì¶óÁøÀº º¸Åë °æ±¸ Åõ¿©µÇ¸ç, ±× È¿°ú°¡ ³ªÅ¸³ª±â±îÁö ½Ã°£ÀÌ °É¸®´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ´Ù¸¥ ¾à¹°°ú ¸¶Âù°¡Áö·Î ºÎÀÛ¿ëÀÌ ÀÖÀ» ¼ö Àֱ⠶§¹®¿¡ ÀÇ·á Àü¹®°¡°¡ ÁÖÀÇ ±í°Ô ¸ð´ÏÅ͸µÇØ¾ß ÇÕ´Ï´Ù. ¼³ÆÄ»ì¶óÁøÀº ƯÁ¤ ¿°Áõ¼º Áúȯ¿¡ ³Î¸® »ç¿ëµÇÁö¸¸, ´Ù¾çÇÑ ÀÛ¿ë±âÀüÀ¸·Î ÀÎÇØ ÀÌ·¯ÇÑ ÁúȯÀÇ ÀÇÇÐÀû °ü¸®¿¡ ÀÖ¾î ±ÍÁßÇÑ Ä¡·á ¿É¼ÇÀ¸·Î ³²¾Æ ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

¼³ÆÄ»ì¶óÁø ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö Áß¿äÇÑ ¿äÀÎÀÇ ¿µÇâÀ» ¹Þ½À´Ï´Ù. ù°, ÀÚ°¡¸é¿ªÁúȯ°ú ¼ÒÈ­±â ÁúȯÀÇ Àü ¼¼°è À¯º´·ü Áõ°¡°¡ Áß¿äÇÑ ÃËÁø¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áúȯ¿¡ ´ëÇÑ Àνİú Áø´ÜÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¼³ÆÄ»ì¶óÁø ¹× À¯»ç ¾à¹°¿¡ ´ëÇÑ ¼ö¿ä°¡ È®´ëµÉ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. µÑ°, Àα¸ °í·ÉÈ­, ƯÈ÷ ½ÅÈï±¹ ½ÃÀå¿¡¼­ÀÇ Àα¸ °í·ÉÈ­°¡ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ³ëÀεéÀº ¿°Áõ¼º Áúȯ¿¡ °É¸®±â ½¬¿ö ¼³ÆÄ»ì¶óÁø°ú °°Àº Àå±âÀûÀÎ °ü¸® ¹× Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ Çʿ伺ÀÌ Áõ°¡ÇÕ´Ï´Ù. ¼Â°, Á¦¾à ¾÷°è¿¡¼­ ÁøÇà ÁßÀÎ ¿¬±¸ °³¹ßÀº ¼³ÆÄ»ì¶óÁøÀÇ º¸´Ù Áøº¸µÇ°í È¿°úÀûÀÎ Á¦ÇüÀ» µµÀÔÇÏ¿© ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù.

±×·¯³ª ½ÃÀåÀº ´ëü Ä¡·á¹ýÀÇ °¡¿ë¼º, ¼³ÆÄ»ì¶óÁø¿¡ µû¸¥ ºÎÀÛ¿ë °¡´É¼º µîÀÇ ¹®Á¦¿¡ Á÷¸éÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á ½Ã½ºÅÛÀÇ ±ÔÁ¦ º¯È­¿Í °¡°Ý ¾Ð·ÂÀº ½ÃÀå ¿ªÇп¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.

º» º¸°í¼­ÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå ºÐ¼® ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦ ¹× µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ¼³ÆÄ»ì¶óÁø ½ÃÀå : ½ÅÇü Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ¼³ÆÄ»ì¶óÁø ½ÃÀå : Á¦Ç° À¯Çüº°(2020-2032³â)

Á¦6Àå ¼¼°èÀÇ ¼³ÆÄ»ì¶óÁø ½ÃÀå : ¿ëµµº°(2020-2032³â)

Á¦7Àå ¼¼°èÀÇ ¼³ÆÄ»ì¶óÁø ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°(2020-2032³â)

Á¦8Àå ¼¼°èÀÇ ¼³ÆÄ»ì¶óÁø ½ÃÀå : Áö¿ªº°(2020-2032³â)

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ¼½¼Ç

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Sulfasalazine Market is estimated to be valued at USD 2.24 Bn in 2025 and is expected to reach USD 3.3 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.7% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 2.24 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 5.70% 2032 Value Projection: USD 3.3 Bn

Sulfasalazine is a medication that falls under the category of disease-modifying antirheumatic drugs (DMARDs) and is primarily used in the treatment of inflammatory conditions, particularly rheumatoid arthritis and inflammatory bowel diseases such as ulcerative colitis and Crohn's disease. The drug is known for its unique combination of sulfapyridine and 5-aminosalicylic acid (5-ASA), both of which contribute to its therapeutic effects. In the context of rheumatoid arthritis, sulfasalazine works by suppressing the immune system's response, mitigating inflammation, and helping to alleviate joint pain and swelling. It is often prescribed as part of a comprehensive treatment plan to manage the symptoms and progression of this chronic autoimmune disorder. Inflammatory bowel diseases involve chronic inflammation of the digestive tract, and sulfasalazine's anti-inflammatory properties are beneficial in treating symptoms associated with ulcerative colitis and Crohn's disease. The 5-ASA component of sulfasalazine is believed to play a key role in this anti-inflammatory action within the gastrointestinal tract. Sulfasalazine is typically administered orally, and its effectiveness often requires some time to become evident. Like any medication, it may have potential side effects, and its use is closely monitored by healthcare professionals. While widely used for specific inflammatory conditions, sulfasalazine's diverse mechanisms of action continue to make it a valuable therapeutic option in the medical management of these diseases.

Market Dynamics

The growth of the sulfasalazine market is influenced by several key factors. First, the rising incidence of autoimmune and gastrointestinal disorders globally is a significant driver. As awareness and diagnosis of these conditions increase, the demand for sulfasalazine and similar medications is likely to grow. Second, the aging population, particularly in developed countries, contributes to the expansion of the market. Older individuals are more susceptible to inflammatory diseases, increasing the need for long-term management and treatment options like sulfasalazine. Third, ongoing research and development in the pharmaceutical industry may lead to the introduction of more advanced and effective formulations of sulfasalazine, further propelling market growth.

However, the market may also face challenges, such as the availability of alternative treatment options and the potential for side effects associated with sulfasalazine. Regulatory changes and pricing pressures in healthcare systems can impact market dynamics.

Key features of the study:

Detailed Segmentation:

Table of Content

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Sulfasalazine Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Sulfasalazine Market, By Product Type, 2020-2032, (US$ Bn)

6. Global Sulfasalazine Market, By Application, 2020-2032, (US$ Bn)

7. Global Sulfasalazine Market, By End User, 2020-2032, (US$ Bn)

8. Global Sulfasalazine Market, By Region, 2020-2032, (US$ Bn)

9. Competitive Landscape

10. Section

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â